Skip to main content

Table 2 Baseline characteristics based on baseline visual acuity

From: Correlation between improvement in visual acuity and QOL after Ranibizumab treatment for age-related macular degeneration patients: QUATRO study

 

Decimal Visual Acuity

Below 0.5

Above 0.6

N = 58

N = 41

Age

74.5 (±7.9)

71.3 (±10.3)

Sex

 Male

45 (77.6%)

32 (78%)

 Female

13 (22.4%)

9 (22%)

Type of AMD

 AMD

51 (87.9%)

32 (78%)

 PCV

4 (6.9%)

9 (22%)

 RAP

3 (5.2%)

.

  1. AMD age-related macular degeneration, PCV polypoidal choroidal vasculopathy, RAP retinal angiomatous proliferation